BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Digklia A, Wagner AD. Advanced gastric cancer: Current treatment landscape and future perspectives. World J Gastroenterol 2016; 22(8): 2403-2414 [PMID: 26937129 DOI: 10.3748/wjg.v22.i8.2403] [Cited by in CrossRef: 162] [Cited by in F6Publishing: 163] [Article Influence: 32.4] [Reference Citation Analysis]
Number Citing Articles
1 Xiang A, Lin X, Xu L, Chen H, Guo J, Zhou F. PCOLCE Is Potent Prognostic Biomarker and Associates With Immune Infiltration in Gastric Cancer. Front Mol Biosci 2020;7:544895. [PMID: 33392251 DOI: 10.3389/fmolb.2020.544895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Abrahao-Machado LF, Scapulatempo-Neto C. HER2 testing in gastric cancer: An update. World J Gastroenterol 2016; 22(19): 4619-4625 [PMID: 27217694 DOI: 10.3748/wjg.v22.i19.4619] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 85] [Article Influence: 16.8] [Reference Citation Analysis]
3 Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, Ho J, Unverzagt S. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2017;8:CD004064. [PMID: 28850174 DOI: 10.1002/14651858.cd004064.pub4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 162] [Article Influence: 19.3] [Reference Citation Analysis]
4 Chen L, Xu M, Zhong W, Hu Y, Wang G. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway. Exp Cell Res 2021;399:112448. [PMID: 33347858 DOI: 10.1016/j.yexcr.2020.112448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Jiang C, Ma Z, Zhang G, Yang X, Du Q, Wang W. CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway. Cancer Manag Res 2019;11:10135-43. [PMID: 31819646 DOI: 10.2147/CMAR.S222620] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
6 Dai Q, Zhang T, Li C. LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway. Cancer Manag Res 2020;12:1929-39. [PMID: 32214850 DOI: 10.2147/CMAR.S243796] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
7 Wang SF, Huang KH, Tseng WC, Lo JF, Li AF, Fang WL, Chen CF, Yeh TS, Chang YL, Chou YC, Hung HH, Lee HC. DNAJA3/Tid1 Is Required for Mitochondrial DNA Maintenance and Regulates Migration and Invasion of Human Gastric Cancer Cells. Cancers (Basel) 2020;12:E3463. [PMID: 33233689 DOI: 10.3390/cancers12113463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sun Z, Zhang J, Li J, Li M, Ge J, Wu P, You B, Qian H. Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy. Stem Cells Int 2021;2021:9962194. [PMID: 34335792 DOI: 10.1155/2021/9962194] [Reference Citation Analysis]
9 Liu S, Zhang Y, Chen L, Guan W, Guan Y, Ge Y, He J, Zhou Z. Whole-lesion apparent diffusion coefficient histogram analysis: significance in T and N staging of gastric cancers. BMC Cancer 2017;17:665. [PMID: 28969606 DOI: 10.1186/s12885-017-3622-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
10 Tan Z. Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review. Med Sci Monit. 2019;25:3537-3541. [PMID: 31080234 DOI: 10.12659/msm.916475] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 20.0] [Reference Citation Analysis]
11 Wu W, Zhen T, Yu J, Yang Q. Circular RNAs as New Regulators in Gastric Cancer: Diagnosis and Cancer Therapy. Front Oncol 2020;10:1526. [PMID: 33072546 DOI: 10.3389/fonc.2020.01526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Shao Z, Yuan C, Hu J, Wu Y, Zeng C. Circ_0003789 Facilitates Gastric Cancer Progression by Inducing the Epithelial-Mesenchymal Transition through the Wnt/β-Catenin Signaling Pathway. Cancer Biotherapy and Radiopharmaceuticals. [DOI: 10.1089/cbr.2020.4044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ye Z, Zheng M, Zeng Y, Wei S, Wang Y, Lin Z, Shu C, Xie Y, Zheng Q, Chen L. Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma. Front Genet 2020;11:595477. [PMID: 33362856 DOI: 10.3389/fgene.2020.595477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang H, Fu T, Zhang C. MicroRNA-1249 Targets G Protein Subunit Alpha 11 and Facilitates Gastric Cancer Cell Proliferation, Motility and Represses Cell Apoptosis. Onco Targets Ther 2021;14:1249-59. [PMID: 33658793 DOI: 10.2147/OTT.S272599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kumar K, Mishra JPN, Singh RP. Usnic acid induces apoptosis in human gastric cancer cells through ROS generation and DNA damage and causes up-regulation of DNA-PKcs and γ-H2A.X phosphorylation. Chem Biol Interact 2020;315:108898. [PMID: 31715134 DOI: 10.1016/j.cbi.2019.108898] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
16 Lv J, Zhang H, Gao Z, Zhang X, Huang X, Jia X. Prognostic value of miR-892a in gastric cancer and its regulatory effect on tumor progression. Cancer Biomark 2020;28:247-54. [PMID: 32390603 DOI: 10.3233/CBM-191323] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Huang Z, He A, Wang J, Lu H, Zhang R, Wu L, Feng Q. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma. Aging (Albany NY) 2021;13:16637-55. [PMID: 34162762 DOI: 10.18632/aging.203184] [Reference Citation Analysis]
18 Zhou D, Zhang Y, Mamtawla G, Wan S, Gao X, Zhang L, Li G, Wang X. Iron overload is related to muscle wasting in patients with cachexia of gastric cancer: using quantitative proteome analysis. Med Oncol 2020;37:113. [PMID: 33196891 DOI: 10.1007/s12032-020-01439-w] [Reference Citation Analysis]
19 Qu J, Yang J, Chen M, Wei R, Tian J. CircFLNA Acts as a Sponge of miR-646 to Facilitate the Proliferation, Metastasis, Glycolysis, and Apoptosis Inhibition of Gastric Cancer by Targeting PFKFB2. Cancer Manag Res 2020;12:8093-103. [PMID: 32982406 DOI: 10.2147/CMAR.S264674] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
20 Neumann PA, Berlet MW, Friess H. Surgical oncology in the age of multimodality therapy for cancer of the upper and lower gastrointestinal tract. Expert Rev Anticancer Ther 2021;21:511-22. [PMID: 33355020 DOI: 10.1080/14737140.2021.1868991] [Reference Citation Analysis]
21 Qu X, Cheng L, Zhao L, Qiu L, Guo W. Functional variation of SLC52A3 rs13042395 predicts survival of Chinese gastric cancer patients. J Cell Mol Med 2020;24:12550-9. [PMID: 32888389 DOI: 10.1111/jcmm.15798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Gao J, Li S, Xu Q, Zhang X, Huang M, Dai X, Liu L. Exosomes Promote Pre-Metastatic Niche Formation in Gastric Cancer. Front Oncol 2021;11:652378. [PMID: 34109113 DOI: 10.3389/fonc.2021.652378] [Reference Citation Analysis]
23 Kim H, Ro SM, Yang JH, Jeong JW, Lee JE, Roh SY, Kim IH. The neutrophil-to-lymphocyte ratio prechemotherapy and postchemotherapy as a prognostic marker in metastatic gastric cancer. Korean J Intern Med 2018;33:990-9. [PMID: 29722249 DOI: 10.3904/kjim.2016.293] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Liu M, Han Z, Zhu QX, Tan J, Liu WJ, Wang YF, Chen W, Zou YL, Cai YS, Tian X, Huang X. Downregulation of liver-intestine cadherin enhances cisplatin-induced apoptosis in human gastric cancer BGC823 cells. Cancer Gene Ther 2018;25:1-9. [PMID: 29203930 DOI: 10.1038/s41417-017-0001-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Petibone DM, Majeed W, Casciano DA. Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity. J Appl Toxicol 2017;37:23-37. [PMID: 27682190 DOI: 10.1002/jat.3393] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
26 Zhang D, Wu P, Zhang Z, An W, Zhang C, Pan S, Tan Y, Xu H. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition. Pathol Res Pract 2020;216:153002. [PMID: 32703484 DOI: 10.1016/j.prp.2020.153002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Liu S, Qiao X, Ji C, Shi H, Wang Y, Li L, Zhou Z. Gastric poorly cohesive carcinoma: differentiation from tubular adenocarcinoma using nomograms based on CT findings in the 40 s late arterial phase. Eur Radiol 2021;31:5768-78. [PMID: 33569616 DOI: 10.1007/s00330-021-07697-0] [Reference Citation Analysis]
28 Liu H, Yao Y, Zhang J, Li J. MEK inhibition overcomes everolimus resistance in gastric cancer. Cancer Chemother Pharmacol 2020;85:1079-87. [PMID: 32444897 DOI: 10.1007/s00280-020-04078-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 Hu ZH, Wang GJ, Li RX, Zhu TY, Wang ZY, Ding HX, Hu XM. Upregulation of miR-133a-3p enhances Bufothionine-induced gastric cancer cell death by modulating IGF1R/PI3K/Akt signal pathway mediated ER stress. Life Sci 2020;259:118180. [PMID: 32758622 DOI: 10.1016/j.lfs.2020.118180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Zhou D, Wu Y, Zhu Y, Lin Z, Yu D, Zhang T. The Prognostic Value of Neutrophil-to-lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Metastatic Gastric Cancer Treated with Systemic Chemotherapy. J Cancer 2020;11:4205-12. [PMID: 32368303 DOI: 10.7150/jca.39575] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
31 Yu S, Zhang Y, Li Q, Zhang Z, Zhao G, Xu J. CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer. Cell Death Dis 2019;10:949. [PMID: 31827075 DOI: 10.1038/s41419-019-2168-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
32 He Z, Dong W, Li Q, Qin C, Li Y. Sauchinone prevents TGF-β-induced EMT and metastasis in gastric cancer cells. Biomedicine & Pharmacotherapy 2018;101:355-61. [DOI: 10.1016/j.biopha.2018.02.121] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
33 Zhang J, Zhang K, Hou Y. Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway. Mol Med Rep 2020;22:687-96. [PMID: 32468065 DOI: 10.3892/mmr.2020.11158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
34 Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Nowak K, Kieser M, Slanger TE, Burmeister B, Kelsen D, Niedzwiecki D, Schuhmacher C, Urba S, van de Velde C, Walsh TN, Ychou M, Jensen K. Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs). Eur J Surg Oncol. 2017;43:1550-1558. [PMID: 28551325 DOI: 10.1016/j.ejso.2017.05.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
35 Fu Y, Chen Y, Huang J, Cai Z, Wang Y. RYK, a receptor of noncanonical Wnt ligand Wnt5a, is positively correlated with gastric cancer tumorigenesis and potential of liver metastasis. Am J Physiol Gastrointest Liver Physiol 2020;318:G352-60. [PMID: 31869240 DOI: 10.1152/ajpgi.00228.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
36 Jin W, Han H, Liu D. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells. CBM 2019;26:183-91. [DOI: 10.3233/cbm-190384] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
37 Dai ZT, Xiang Y, Zhang XY, Zong QB, Wu QF, Huang Y, Shen C, Li JP, Ponnambalam S, Liao XH. Regulation of follistatin-like 3 expression by miR-486-5p modulates gastric cancer cell proliferation, migration and tumor progression. Aging (Albany NY) 2021;13:20302-18. [PMID: 34425560 DOI: 10.18632/aging.203412] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Liang X, Wang P, Yang C, Huang F, Wu H, Shi H, Wu X. Galangin Inhibits Gastric Cancer Growth Through Enhancing STAT3 Mediated ROS Production. Front Pharmacol 2021;12:646628. [PMID: 33981228 DOI: 10.3389/fphar.2021.646628] [Reference Citation Analysis]
39 He X, Zhang T, Wu L, Wu Y, Zhou X. The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24110. [PMID: 33466182 DOI: 10.1097/MD.0000000000024110] [Reference Citation Analysis]
40 Kim JW, Kim JG, Kang BW, Chung IJ, Hong YS, Kim TY, Song HS, Lee KH, Zang DY, Ko YH, Song EK, Baek JH, Koo DH, Oh SY, Cho H, Lee KW. Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer. Cancer Res Treat 2019;51:223-39. [PMID: 30584995 DOI: 10.4143/crt.2018.073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
41 Xu J, Ou X, Li J, Cai Q, Sun K, Ye J, Peng J. Overexpression of TC2N is associated with poor prognosis in gastric cancer. J Cancer 2021;12:807-17. [PMID: 33403038 DOI: 10.7150/jca.50653] [Reference Citation Analysis]
42 Peeters M, Cervantes A, Moreno Vera S, Taieb J. Trifluridine/tipiracil: an emerging strategy for the management of gastrointestinal cancers. Future Oncology 2018;14:1629-45. [DOI: 10.2217/fon-2018-0147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
43 Díaz Del Arco C, Ortega Medina L, Estrada Muñoz L, García Gómez de Las Heras S, Fernández Aceñero MJ. Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis. Histol Histopathol 2021;36:587-613. [PMID: 33565601 DOI: 10.14670/HH-18-309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Meng L, Ding L, Yu Y, Li W. JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma. Biomed Res Int 2020;2020:7973568. [PMID: 33083484 DOI: 10.1155/2020/7973568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Bang YJ, Ruiz EY, Van Cutsem E, Lee KW, Wyrwicz L, Schenker M, Alsina M, Ryu MH, Chung HC, Evesque L, Al-Batran SE, Park SH, Lichinitser M, Boku N, Moehler MH, Hong J, Xiong H, Hallwachs R, Conti I, Taieb J. Phase III, randomised trial of avelumab vs physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300. Ann Oncol. 2018;29:2052-2060. [PMID: 30052729 DOI: 10.1093/annonc/mdy264] [Cited by in Crossref: 169] [Cited by in F6Publishing: 174] [Article Influence: 84.5] [Reference Citation Analysis]
46 Li XM, Jiao YY, Luan BH, Wu HX, Wang RR, Zhong J. Long non-coding RNA MIAT promotes gastric cancer proliferation and metastasis via modulating the miR-331-3p/RAB5B pathway. Oncol Lett 2020;20:355. [PMID: 33154765 DOI: 10.3892/ol.2020.12219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 He ZC, Yang F, Guo LL, Wei Z, Dong X. LncRNA TP73-AS1 promotes the development of Epstein-Barr virus associated gastric cancer by recruiting PRC2 complex to regulate WIF1 methylation. Cell Signal 2021;:110094. [PMID: 34314802 DOI: 10.1016/j.cellsig.2021.110094] [Reference Citation Analysis]
48 Haehnel S, Reiche K, Loeffler D, Horn A, Blumert C, Puppel SH, Kaiser N, Rapp F, Rade M, Horn F, Meixensberger J, Bechmann I, Gaunitz F, Winter K. Deep sequencing and automated histochemistry of human tissue slice cultures improve their usability as preclinical model for cancer research. Sci Rep 2019;9:19961. [PMID: 31882946 DOI: 10.1038/s41598-019-56509-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Yao Y, Deng R, Liao D, Xie H, Zuo J, Jia Y, Kong F. Maintenance treatment in advanced HER2-negative gastric cancer. Clin Transl Oncol 2020;22:2206-12. [PMID: 32562198 DOI: 10.1007/s12094-020-02379-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Shen K, Liu T. Comprehensive Analysis of the Prognostic Value and Immune Function of Immune Checkpoints in Stomach Adenocarcinoma. Int J Gen Med 2021;14:5807-24. [PMID: 34557032 DOI: 10.2147/IJGM.S325467] [Reference Citation Analysis]
51 Zhang Y, Pei J, Shi S, Guo X, Cui G, Li Y, Zhang H, Hu W. CRISPR/Cas9-mediated knockout of the PDEF gene inhibits migration and invasion of human gastric cancer AGS cells. Biomedicine & Pharmacotherapy 2019;111:76-85. [DOI: 10.1016/j.biopha.2018.12.048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
52 Liu W, Lu Y, Chai X, Liu X, Zhu T, Wu X, Fang Y, Liu X, Zhang X. Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases. J Exp Clin Cancer Res 2016;35:183. [PMID: 27887633 DOI: 10.1186/s13046-016-0464-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
53 Han F, Shrestha S, Huang H, Lv HY, Nie C, Lin L, Lu ML. Expression of annexin II in gastric carcinoma and its role in gastric cancer metastasis. World J Gastroenterol 2017; 23(38): 7009-7015 [PMID: 29097873 DOI: 10.3748/wjg.v23.i38.7009] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
54 Xuan Y, Wang Y. Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation. Cell Death Dis. 2019;10:694. [PMID: 31534128 DOI: 10.1038/s41419-019-1940-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
55 Fu J, Tang L, Li ZY, Li XT, Zhu HF, Sun YS, Ji JF. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy. Eur J Radiol 2020;128:108974. [PMID: 32416553 DOI: 10.1016/j.ejrad.2020.108974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Yoo SH, Kang SY, Yoon J, Kim TY, Cheon GJ, Oh DY. Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy. Sci Rep 2021;11:296. [PMID: 33436659 DOI: 10.1038/s41598-020-78963-2] [Reference Citation Analysis]
57 Mu C, Peng RK, Guo CL, Li A, Yang XM, Zeng R, Li YL, Gu J, Ouyang Q. Discovery of sertraline and its derivatives able to combat drug-resistant gastric cancer cell via inducing apoptosis. Bioorg Med Chem Lett 2021;41:127997. [PMID: 33775839 DOI: 10.1016/j.bmcl.2021.127997] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 O'Leary BR, Houwen FK, Johnson CL, Allen BG, Mezhir JJ, Berg DJ, Cullen JJ, Spitz DR. Pharmacological Ascorbate as an Adjuvant for Enhancing Radiation-Chemotherapy Responses in Gastric Adenocarcinoma. Radiat Res 2018;189:456-65. [PMID: 29547353 DOI: 10.1667/RR14978.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
59 Sughayer MA, Dabbagh TZ, Battah AH. PD-L1 Expression Is a Favorable Prognostic Marker in Gastric Carcinoma. Appl Immunohistochem Mol Morphol 2020;28:748-54. [PMID: 32205740 DOI: 10.1097/PAI.0000000000000834] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Luo Y, Wu J, Wu Q, Li X, Wu J, Zhang J, Rong X, Rao J, Liao Y, Bin J, Huang N, Liao W. miR-577 Regulates TGF-β Induced Cancer Progression through a SDPR-Modulated Positive-Feedback Loop with ERK-NF-κB in Gastric Cancer. Mol Ther 2019;27:1166-82. [PMID: 30879950 DOI: 10.1016/j.ymthe.2019.02.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
61 Li Y, Zhong X, Zhang Y, Lu X. Mesenchymal Stem Cells in Gastric Cancer: Vicious but Hopeful. Front Oncol 2021;11:617677. [PMID: 34046337 DOI: 10.3389/fonc.2021.617677] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Zhang Y, Chen J, Che Z, Shu C, Chen D, Ding K, Li A, Zhou J. JP3 enhances the toxicity of cisplatin on drug-resistant gastric cancer cells while reducing the damage to normal cells. J Cancer 2021;12:1894-906. [PMID: 33753987 DOI: 10.7150/jca.50306] [Reference Citation Analysis]
63 Shen K, Yu W, Yu Y, Liu X, Cui X. Knockdown of TMEM45B inhibits cell proliferation and invasion in gastric cancer. Biomedicine & Pharmacotherapy 2018;104:576-81. [DOI: 10.1016/j.biopha.2018.05.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
64 Cheng Z, Gao S, Liang X, Lian C, Chen J, Fang C. Inhibiting PP2Acα Promotes the Malignant Phenotype of Gastric Cancer Cells through the ATM/METTL3 Axis. Biomed Res Int 2021;2021:1015293. [PMID: 34485508 DOI: 10.1155/2021/1015293] [Reference Citation Analysis]
65 Li Y, Xie D, Chen X, Hu T, Lu S, Han Y. Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study. Technol Cancer Res Treat 2020;19:1533033820964131. [PMID: 33111644 DOI: 10.1177/1533033820964131] [Reference Citation Analysis]
66 He W, Liang B, Wang C, Li S, Zhao Y, Huang Q, Liu Z, Yao Z, Wu Q, Liao W, Zhang S, Liu Y, Xiang Y, Liu J, Shi M. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer. Oncogene 2019;38:4637-54. [PMID: 30742067 DOI: 10.1038/s41388-019-0747-0] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 32.0] [Reference Citation Analysis]
67 Zhang H, Sun Z, Li Y, Fan D, Jiang H. MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells. Biomed Pharmacother 2017;88:285-92. [PMID: 28113080 DOI: 10.1016/j.biopha.2017.01.023] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
68 Zhang L, Zou L, Sun P. Relationship between miR-378c and YY1 expression in patients with gastric cancer and the clinicopathological features. Cell Mol Biol Lett 2021;26:12. [PMID: 33794762 DOI: 10.1186/s11658-021-00256-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Li Z, Suo B, Long G, Gao Y, Song J, Zhang M, Feng B, Shang C, Wang D. Exosomal miRNA-16-5p Derived From M1 Macrophages Enhances T Cell-Dependent Immune Response by Regulating PD-L1 in Gastric Cancer. Front Cell Dev Biol 2020;8:572689. [PMID: 33330451 DOI: 10.3389/fcell.2020.572689] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
70 Ke B, Wang XN, Liu N, Li B, Wang XJ, Zhang RP, Liang H. Sonic Hedgehog/Gli1 Signaling Pathway Regulates Cell Migration and Invasion via Induction of Epithelial-to-mesenchymal Transition in Gastric Cancer. J Cancer 2020;11:3932-43. [PMID: 32328197 DOI: 10.7150/jca.42900] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
71 Jiao X, Qian X, Wu L, Li B, Wang Y, Kong X, Xiong L. microRNA: The Impact on Cancer Stemness and Therapeutic Resistance. Cells 2019;9:E8. [PMID: 31861404 DOI: 10.3390/cells9010008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
72 Yang S, He X, Liu Y, Ding X, Jiang H, Tan Y, Lu H. Prognostic Significance of Serum Uric Acid and Gamma-Glutamyltransferase in Patients with Advanced Gastric Cancer. Dis Markers 2019;2019:1415421. [PMID: 31885729 DOI: 10.1155/2019/1415421] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
73 Yang N, Wu Y, Jin M, Jia Z, Wang Y, Cao D, Qin L, Wang X, Zheng M, Cao X, Jiang J. Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer. PeerJ 2021;9:e11481. [PMID: 34046266 DOI: 10.7717/peerj.11481] [Reference Citation Analysis]
74 Xue S, Ma M, Bei S, Li F, Wu C, Li H, Hu Y, Zhang X, Qian Y, Qin Z, Jiang J, Feng L. Identification and Validation of the Immune Regulator CXCR4 as a Novel Promising Target for Gastric Cancer. Front Immunol 2021;12:702615. [PMID: 34322132 DOI: 10.3389/fimmu.2021.702615] [Reference Citation Analysis]
75 Luo T, Li Y, Nie R, Liang C, Liu Z, Xue Z, Chen G, Jiang K, Liu ZX, Lin H, Li C, Chen Y. Development and validation of metabolism-related gene signature in prognostic prediction of gastric cancer. Comput Struct Biotechnol J 2020;18:3217-29. [PMID: 33209209 DOI: 10.1016/j.csbj.2020.09.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Zhu L, Wang C, Lin S, Zong L. CircKIAA0907 Retards Cell Growth, Cell Cycle, and Autophagy of Gastric Cancer In Vitro and Inhibits Tumorigenesis In Vivo via the miR-452-5p/KAT6B Axis. Med Sci Monit 2020;26:e924160. [PMID: 32722658 DOI: 10.12659/MSM.924160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Gao S, Song D, Liu Y, Yan H, Chen X. Helicobacter pylori CagA Protein Attenuates 5-Fu Sensitivity of Gastric Cancer Cells Through Upregulating Cellular Glucose Metabolism. Onco Targets Ther 2020;13:6339-49. [PMID: 32753880 DOI: 10.2147/OTT.S230875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
78 Ren Z, Liu X, Si Y, Yang D. Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis. Artif Cells Nanomed Biotechnol 2020;48:572-83. [PMID: 32054332 DOI: 10.1080/21691401.2020.1726937] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
79 Jian D, Qian C, Wang D, Ma Q, Wang L, Li C, Xu M, Dai N, Chen Q, He J, Zhang H, Yuan M, Chen R, Chao R, Feng Y. Conversion therapy with tislelizumab for high microsatellite instability, unresectable stage III gastric cancer: a case report. Ann Transl Med 2021;9:1489. [PMID: 34734041 DOI: 10.21037/atm-21-4295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Wang S, Ni B, Zhang Z, Wang C, Wo L, Zhou C, Zhao Q, Zhao E. Long non-coding RNA DNM3OS promotes tumor progression and EMT in gastric cancer by associating with Snail. Biochem Biophys Res Commun 2019;511:57-62. [PMID: 30770102 DOI: 10.1016/j.bbrc.2019.02.030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
81 Yang Y, Qiu Y, Tang M, Wu Z, Hu W, Chen C. Expression and function of transforming growth factor‑β‑activated protein kinase 1 in gastric cancer. Mol Med Rep 2017;16:3103-10. [PMID: 28714004 DOI: 10.3892/mmr.2017.6998] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
82 Wang BC, Zhang ZJ, Fu C, Wang C. Efficacy and safety of anti-PD-1/PD-L1 agents vs chemotherapy in patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e18054. [PMID: 31764833 DOI: 10.1097/MD.0000000000018054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
83 Qi J, Liu S, Liu W, Cai G, Liao G. Identification of UAP1L1 as tumor promotor in gastric cancer through regulation of CDK6. Aging (Albany NY) 2020;12:6904-27. [PMID: 32310823 DOI: 10.18632/aging.103050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
84 Li G, Zhang T, Huang K, Zhu Y, Xu K, Gu J, Huang S, Gu C, Zhan R, Shen J. Long noncoding RNA GAS8-AS1: A novel biomarker in human diseases. Biomed Pharmacother 2021;139:111572. [PMID: 33838502 DOI: 10.1016/j.biopha.2021.111572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Moehler M, Dvorkin M, Boku N, Özgüroğlu M, Ryu MH, Muntean AS, Lonardi S, Nechaeva M, Bragagnoli AC, Coşkun HS, Cubillo Gracian A, Takano T, Wong R, Safran H, Vaccaro GM, Wainberg ZA, Silver MR, Xiong H, Hong J, Taieb J, Bang YJ. Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100. J Clin Oncol 2021;39:966-77. [PMID: 33197226 DOI: 10.1200/JCO.20.00892] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
86 Ba L, Xue C, Li X, Zhang M, Yang Y, Han Q, Sun Z, Zhao RC. Gastric Cancer Cell-Derived Exosomes Can Regulate the Biological Functions of Mesenchymal Stem Cells by Inducing the Expression of Circular RNA circ_0004303. Stem Cells Dev 2021;30:830-42. [PMID: 34098776 DOI: 10.1089/scd.2021.0059] [Reference Citation Analysis]
87 Cheng H, Sun A, Guo Q, Zhang Y. Efficacy and safety of apatinib combined with chemotherapy for the treatment of advanced gastric cancer in the Chinese population: a systematic review and meta-analysis. Drug Des Devel Ther 2018;12:2173-83. [PMID: 30034222 DOI: 10.2147/DDDT.S170678] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
88 Ding L, Li B, Yu X, Li Z, Li X, Dang S, Lv Q, Wei J, Sun H, Chen H, Liu M, Li G. KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis. Cancer Cell Int 2020;20:125. [PMID: 32322172 DOI: 10.1186/s12935-020-01199-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
89 Xie X, Zhou Z, Song Y, Zhang X, Dang C, Zhang H. Mist1 Inhibits Epithelial-Mesenchymal Transition in Gastric Adenocarcinoma via Downregulating the Wnt/β-catenin Pathway. J Cancer 2021;12:4574-84. [PMID: 34149921 DOI: 10.7150/jca.59138] [Reference Citation Analysis]
90 Ding F, Zhu X, Song X, Yuan P, Ren L, Chai C, Zhou W, Li X. UBR5 oncogene as an indicator of poor prognosis in gastric cancer. Exp Ther Med 2020;20:7. [PMID: 32934672 DOI: 10.3892/etm.2020.9135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
91 Wang J, Xu P, Hao Y, Yu T, Liu L, Song Y, Li Y. Interaction between DNMT3B and MYH11 via hypermethylation regulates gastric cancer progression. BMC Cancer 2021;21:914. [PMID: 34380460 DOI: 10.1186/s12885-021-08653-3] [Reference Citation Analysis]
92 Guo Q, Jing FJ, Qu HJ, Xu W, Han B, Xing XM, Ji HY, Jing FB. Ubenimex Reverses MDR in Gastric Cancer Cells by Activating Caspase-3-Mediated Apoptosis and Suppressing the Expression of Membrane Transport Proteins. Biomed Res Int 2019;2019:4390839. [PMID: 30915355 DOI: 10.1155/2019/4390839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
93 Chuang YC, Wu HY, Lin YL, Tzou SC, Chuang CH, Jian TY, Chen PR, Chang YC, Lin CH, Huang TH, Wang CC, Chan YL, Liao KW. Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric Cancer. Biol Proced Online 2018;20:10. [PMID: 29743821 DOI: 10.1186/s12575-018-0073-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
94 Tanaka O, Omatsu T, Kariya S, Maejima R, Taniguchi T, Ono K, Kunishima Y, Matsuo M. Usefulness of diffusion-weighted magnetic resonance imaging for evaluating the effect of hemostatic radiotherapy for unresectable gastric cancer. Clin J Gastroenterol 2019;12:269-73. [PMID: 30446953 DOI: 10.1007/s12328-018-0923-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
95 Nie ML, Han J, Huang HC, Guo T, Huangfu LT, Cheng XJ, Li XM, Du H, Li QD, Wen XZ, Ji JF. The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis. Cancer Manag Res 2019;11:5375-91. [PMID: 31354346 DOI: 10.2147/CMAR.S201793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
96 Liu H, Liu M, He B, Li Q. Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways. Clin Res Hepatol Gastroenterol 2021;:101779. [PMID: 34332125 DOI: 10.1016/j.clinre.2021.101779] [Reference Citation Analysis]
97 Zhang Q, Wang X, Cao S, Sun Y, He X, Jiang B, Yu Y, Duan J, Qiu F, Kang N. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways. Biomed Pharmacother 2020;128:110245. [PMID: 32454290 DOI: 10.1016/j.biopha.2020.110245] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
98 Dong X, Chen R, Lin H, Lin T, Pan S. lncRNA BG981369 Inhibits Cell Proliferation, Migration, and Invasion, and Promotes Cell Apoptosis by SRY-Related High-Mobility Group Box 4 (SOX4) Signaling Pathway in Human Gastric Cancer. Med Sci Monit 2018;24:718-26. [PMID: 29398692 DOI: 10.12659/msm.905965] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
99 Wu JQ, Zhai J, Li CY, Tan AM, Wei P, Shen LZ, He MF. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. J Exp Clin Cancer Res. 2017;36:160. [PMID: 29141689 DOI: 10.1186/s13046-017-0631-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
100 Lin M, Xu M, Xu Z, Weng Z, Lin B, Lan Y, Liu Q, Lin X, Pan J. LINC00200 contributes to the chemoresistance to oxaliplatin of gastric cancer cells via regulating E2F1/RAD51 axis. Hum Cell 2021;34:1163-73. [PMID: 33822325 DOI: 10.1007/s13577-021-00523-1] [Reference Citation Analysis]
101 Gao Y, Chu Y, Hu Q, Song Q. Primary tumor resection benefited the survival of patients with distant metastatic gastric cancer. J Res Med Sci 2021;26:24. [PMID: 34221053 DOI: 10.4103/jrms.JRMS_73_20] [Reference Citation Analysis]
102 Ke B, Guo XF, Li N, Wu LL, Li B, Zhang RP, Liang H. Clinical significance of Stathmin1 expression and epithelial-mesenchymal transition in curatively resected gastric cancer. Mol Clin Oncol 2019;10:214-22. [PMID: 30680197 DOI: 10.3892/mco.2018.1774] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
103 Jung M, Yang Y, McCloskey JE, Zaman M, Vedvyas Y, Zhang X, Stefanova D, Gray KD, Min IM, Zarnegar R, Choi YY, Cheong JH, Noh SH, Rha SY, Chung HC, Jin MM. Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer. Mol Ther Oncolytics 2020;18:587-601. [PMID: 32995483 DOI: 10.1016/j.omto.2020.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
104 Guo Q, Jing FJ, Xu W, Li X, Li X, Sun JL, Xing XM, Zhou CK, Jing FB. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis. Aging (Albany NY) 2019;12:80-105. [PMID: 31895687 DOI: 10.18632/aging.102598] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
105 Zhang W, Liao K, Liu D. MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK. Cancer Manag Res 2020;12:8137-47. [PMID: 32982411 DOI: 10.2147/CMAR.S253777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
106 Menghani SV, Barbosa A, Sagerman P, Beal MW, Scott A. Gastric Cardia Adenocarcinoma with Metastasis to the Scalp: A Case Report. Cureus 2020;12:e6781. [PMID: 32140341 DOI: 10.7759/cureus.6781] [Reference Citation Analysis]
107 Zhang Q, Zhang H, Ning T, Liu D, Deng T, Liu R, Bai M, Zhu K, Li J, Fan Q, Ying G, Ba Y. Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer. Int J Nanomedicine 2020;15:2323-35. [PMID: 32308384 DOI: 10.2147/IJN.S231214] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 22.0] [Reference Citation Analysis]
108 Bian J, Long JY, Yang X, Yang XB, Xu YY, Lu X, Sang XT, Zhao HT. Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer. World J Gastroenterol 2020; 26(41): 6414-6430 [PMID: 33244202 DOI: 10.3748/wjg.v26.i41.6414] [Reference Citation Analysis]
109 Ertürk SA, Hasbek Z, Özer H. The Relationship Between HER-2 Expression Levels and 18F-FDG PET/CT Parameters in Gastric Cancer. Mol Imaging Radionucl Ther 2021;30:150-7. [PMID: 34658230 DOI: 10.4274/mirt.galenos.2021.78055] [Reference Citation Analysis]
110 Novick D, Leonardi F, Lee Kay Pen D, Montoya-restrepo ME, Avendaño C, Siddi S, Moneta MV, Haro JM, Velasquez JC. Retrospective analysis of patients with advanced or metastatic gastric cancer in Colombia. Journal of Medical Economics 2019;22:891-900. [DOI: 10.1080/13696998.2019.1617161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Wan X, Song Y, Fang H, Xu L, Che X, Wang S, Zhang X, Zhang L, Li C, Fan Y, Hou K, Li Z, Wang X, Liu Y, Qu X. RANKL/RANK promotes the migration of gastric cancer cells by interacting with EGFR. Clin Transl Med 2020;9:3. [PMID: 31933009 DOI: 10.1186/s40169-019-0249-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
112 Yang Y, Wang C, Dai C, Liu X, Li W, Huang M, Zhao X, Ji D, Li J, Guo W. Amplification and expression of c-MET correlate with poor prognosis of patients with gastric cancer and upregulate the expression of PDL1. Acta Biochim Biophys Sin (Shanghai) 2021;53:547-57. [PMID: 33693450 DOI: 10.1093/abbs/gmab026] [Reference Citation Analysis]
113 Zhang Y, Lin Y, Duan J, Xu K, Mao M, Wang X. A Population-Based Analysis of Distant Metastasis in Stage IV Gastric Cancer. Med Sci Monit 2020;26:e923867. [PMID: 32409630 DOI: 10.12659/MSM.923867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
114 Jian Y, Zhao M, Cao J, Fan T, Bu W, Yang Y, Li W, Zhang W, Qiao Y, Wang J, Wen A. A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity. Drug Des Devel Ther 2020;14:2355-70. [PMID: 32606603 DOI: 10.2147/DDDT.S233023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Wei J, Gao X, Qin Y, Liu T, Kang Y. An Iron Metabolism-Related SLC22A17 for the Prognostic Value of Gastric Cancer. Onco Targets Ther 2020;13:12763-75. [PMID: 33363382 DOI: 10.2147/OTT.S287811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
116 Koh J, Nam SK, Lee YW, Kim JW, Lee KW, Ock CY, Oh DY, Ahn SH, Kim HH, Kang KW, Kim WH, Lee HY, Lee HS. Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients. Biomolecules 2019;9:E782. [PMID: 31779184 DOI: 10.3390/biom9120782] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Kim SW, Jeong G, Ryu MH, Park YS. Comparison of PD-L1 immunohistochemical assays in advanced gastric adenocarcinomas using endoscopic biopsy and paired resected specimens. Pathology 2021;53:586-94. [PMID: 33546812 DOI: 10.1016/j.pathol.2020.10.015] [Reference Citation Analysis]
118 Song XL, Kang HK, Jeong GW, Ahn KY, Jeong YY, Kang YJ, Cho HJ, Moon CM. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer. World J Gastroenterol 2016; 22(24): 5520-5531 [PMID: 27350730 DOI: 10.3748/wjg.v22.i24.5520] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
119 Espadinha M, Barcherini V, Gonçalves LM, Molins E, Antunes AMM, Santos MMM. Tryptophanol-Derived Oxazolopyrrolidone Lactams as Potential Anticancer Agents against Gastric Adenocarcinoma. Pharmaceuticals (Basel) 2021;14:208. [PMID: 33801507 DOI: 10.3390/ph14030208] [Reference Citation Analysis]
120 Ma R, Shimura T, Yin C, Okugawa Y, Kitajima T, Koike Y, Okita Y, Ohi M, Uchida K, Goel A, Yao L, Zhang X, Toiyama Y. Antitumor effects of Andrographis via ferroptosis-associated genes in gastric cancer. Oncol Lett 2021;22:523. [PMID: 34025790 DOI: 10.3892/ol.2021.12784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Zhao D, Klempner SJ, Chao J. Progress and challenges in HER2-positive gastroesophageal adenocarcinoma. J Hematol Oncol 2019;12:50. [PMID: 31101074 DOI: 10.1186/s13045-019-0737-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
122 Wang X, Zhang H, Bai M, Ning T, Ge S, Deng T, Liu R, Zhang L, Ying G, Ba Y. Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer. Mol Ther. 2018;26:774-783. [PMID: 29456019 DOI: 10.1016/j.ymthe.2018.01.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 22.0] [Reference Citation Analysis]
123 Park S, Nam CM, Kim SG, Mun JE, Rha SY, Chung HC. Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis. Eur J Cancer 2021;144:49-60. [PMID: 33338727 DOI: 10.1016/j.ejca.2020.10.030] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
124 Fan H, Jin X, Liao C, Qiao L, Zhao W. MicroRNA-301b-3p accelerates the growth of gastric cancer cells by targeting zinc finger and BTB domain containing 4. Pathol Res Pract 2019;215:152667. [PMID: 31585814 DOI: 10.1016/j.prp.2019.152667] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
125 Aurello P, Petrucciani N, Antolino L, Giulitti D, D'Angelo F, Ramacciato G. Follow-up after curative resection for gastric cancer: Is it time to tailor it? World J Gastroenterol 2017; 23(19): 3379-3387 [PMID: 28596674 DOI: 10.3748/wjg.v23.i19.3379] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
126 Zhang S, Li Z, Dong H, Wu P, Liu Y, Guo T, Li C, Wang S, Qu X, Liu Y, Che X, Xu L. Construction of an immune-related gene signature to predict survival and treatment outcome in gastric cancer. Sci Prog 2021;104:36850421997286. [PMID: 33661721 DOI: 10.1177/0036850421997286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Bai M, Wang P, Yang J, Zuo M, Ba Y. Identification of miR-135b as a novel regulator of TGFβ pathway in gastric cancer. J Physiol Biochem 2020;76:549-60. [PMID: 32737704 DOI: 10.1007/s13105-020-00759-9] [Reference Citation Analysis]
128 Magalhães H, Fontes-Sousa M, Machado M. Immunotherapy in Advanced Gastric Cancer: An Overview of the Emerging Strategies. Can J Gastroenterol Hepatol 2018;2018:2732408. [PMID: 30027089 DOI: 10.1155/2018/2732408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
129 Wang CY, Yang J, Zi H, Zheng ZL, Li BH, Wang Y, Ge Z, Jian GX, Lyu J, Li XD, Ren XQ. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy. BMC Cancer 2020;20:10. [PMID: 31906882 DOI: 10.1186/s12885-019-6495-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
130 Zhu DL, Shuai LY. Effects of Birinapant on Proliferation and Invasion of MGC-803 Gastric Cancer Cells and Mechanism Underlying These Effects. Bull Exp Biol Med 2021;171:56-61. [PMID: 34050412 DOI: 10.1007/s10517-021-05172-w] [Reference Citation Analysis]
131 Fu S, Yan J, Tan Y, Liu D. Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: a meta-analysis. J Gastrointest Oncol 2021;12:344-54. [PMID: 34012630 DOI: 10.21037/jgo-20-252] [Reference Citation Analysis]
132 Sun L, Wang H, Liu Z, Meng Y, Qiu M, Ju Y, Zhang S. Outcomes of 596 Advanced Gastric Cancer Patients with Different Numbers of Chemotherapy Lines: The More Chemotherapy Lines, the Better Survival. Cancer Manag Res 2020;12:10631-8. [PMID: 33149671 DOI: 10.2147/CMAR.S275990] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Hayashi M, Yoshikawa T, Yura M, Otsuki S, Yamagata Y, Morita S, Katai H, Nishida T. Predictive value of the surgical Apgar score on postoperative complications in advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by radical gastrectomy: a single-center retrospective study. BMC Surg 2020;20:150. [PMID: 32652977 DOI: 10.1186/s12893-020-00813-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
134 Kang HM, Kim GH, Jeon HK, Kim DH, Jeon TY, Park DY, Jeong H, Chun WJ, Kim MH, Park J, Lim M, Kim TH, Cho YK. Circulating tumor cells detected by lab-on-a-disc: Role in early diagnosis of gastric cancer. PLoS One. 2017;12:e0180251. [PMID: 28662130 DOI: 10.1371/journal.pone.0180251] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
135 Yu S, Li Q, Yu Y, Cui Y, Li W, Liu T, Liu F. Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer. Cancer Immunol Immunother 2020;69:1973-87. [PMID: 32388677 DOI: 10.1007/s00262-020-02598-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
136 Wu M, Hu W, Wang G, Yao Y, Yu XF. Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer. Front Genet 2020;11:580299. [PMID: 33193702 DOI: 10.3389/fgene.2020.580299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Mora-Lagos B, Cartas-Espinel I, Riquelme I, Parker AC, Piccolo SR, Viscarra T, Reyes ME, Zanella L, Buchegger K, Ili C, Brebi P. Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines. PLoS One 2020;15:e0228331. [PMID: 31990955 DOI: 10.1371/journal.pone.0228331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
138 Pan X, Tao H, Nie M, Liu Y, Huang P, Liu S, Sun W, Wu J, Ma T, Dai A, Lu J, Liu B, Zou X, Sun Q. A clinical study of traditional Chinese medicine prolonging the survival of advanced gastric cancer patients by regulating the immunosuppressive cell population: A study protocol for a multicenter, randomized controlled trail. Medicine (Baltimore) 2020;99:e19757. [PMID: 32311976 DOI: 10.1097/MD.0000000000019757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
139 Xu Y, Feng S, Niu B. Silencing Stat3 inhibits viability and induces apoptosis in BGC-823 human gastric cancer cell line. Biotech Histochem 2021;96:76-81. [PMID: 32619110 DOI: 10.1080/10520295.2020.1770332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Yang H, Zhou Y, Wang L, Gu T, Lv M, Sun J, Tu C, He J. The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs. Gastroenterol Res Pract 2021;2021:8960315. [PMID: 33679971 DOI: 10.1155/2021/8960315] [Reference Citation Analysis]
141 Zheng Z, Guo Y, Zou CP. Oncological outcomes of addition of anti-PD1/PD-L1 to chemotherapy in the therapy of patients with advanced gastric or gastro-oesophageal junction cancer: A meta-analysis. Medicine (Baltimore) 2020;99:e18332. [PMID: 32049776 DOI: 10.1097/MD.0000000000018332] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Song J, Guan Z, Li M, Sha S, Song C, Gao Z, Zhao Y. MicroRNA-154 Inhibits the Growth and Invasion of Gastric Cancer Cells by Targeting DIXDC1/WNT Signaling. Oncol Res 2018;26:847-56. [PMID: 28800791 DOI: 10.3727/096504017X15016337254632] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
143 Kong F, Yao Y, Deng R, Li X, Jia Y. Hopes and failures in front-line advanced HER2-positive gastric cancer therapy. Anticancer Drugs 2021;32:675-80. [PMID: 33929993 DOI: 10.1097/CAD.0000000000001081] [Reference Citation Analysis]
144 Wang Y, Yu Y, Han W, Zhang YJ, Jiang L, Xue HD, Lei J, Jin ZY, Yu JC. CT Radiomics for Distinction of Human Epidermal Growth Factor Receptor 2 Negative Gastric Cancer. Acad Radiol 2021;28:e86-92. [PMID: 32303442 DOI: 10.1016/j.acra.2020.02.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Li Z, Fan H, Chen W, Xiao J, Ma X, Ni P, Xu Z, Yang L. MicroRNA-653-5p Promotes Gastric Cancer Proliferation and Metastasis by Targeting the SOCS6-STAT3 Pathway. Front Mol Biosci 2021;8:655580. [PMID: 33937336 DOI: 10.3389/fmolb.2021.655580] [Reference Citation Analysis]
146 Li Y, Yan J, Wang Y, Wang C, Zhang C, Li G. LINC00240 promotes gastric cancer cell proliferation, migration and EMT via the miR-124-3p / DNMT3B axis. Cell Biochem Funct 2020;38:1079-88. [PMID: 32526811 DOI: 10.1002/cbf.3551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
147 Gürbüz M, Akkuş E, Sakin A, Urvay S, Demiray AG, Şahin S, Şakalar T, Erol C, Şendur MAN, Şahin AB, Çubukçu E, Güven DC, Kılıçkap S, Ergün Y, Uncu D, Turhal NS, Üskent N, Yeşil Çınkır H, Demir A, Acar R, Karadurmuş N, Türker S, Altınbaş M, Karaoğlan M, Çay Şenler F. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer. Tumori 2020;:300891620969823. [PMID: 33167790 DOI: 10.1177/0300891620969823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Spirina LV, Avgustinovich AV, Afanas'ev SG, Cheremisina OV, Volkov MY, Choynzonov EL, Gorbunov AK, Usynin EA. Molecular Mechanism of Resistance to Chemotherapy in Gastric Cancers, the Role of Autophagy. Curr Drug Targets 2020;21:713-21. [PMID: 31775598 DOI: 10.2174/1389450120666191127113854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
149 Zhang D, Li S, Yu W, Chen C, Liu T, Sun Y, Zhao Z, Liu L. LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1. Cancer Manag Res 2018;10:4349-61. [PMID: 30349368 DOI: 10.2147/CMAR.S174856] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
150 Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J, Jiang Z, Zhang Y, Xu G, Zhang J, Zhou J, Sun B, Zou X, Wang S. METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut 2020;69:1193-205. [PMID: 31582403 DOI: 10.1136/gutjnl-2019-319639] [Cited by in Crossref: 116] [Cited by in F6Publishing: 127] [Article Influence: 58.0] [Reference Citation Analysis]
151 Huang B, Chang C, Wang BL, Li H. ELK1-induced upregulation of lncRNA TRPM2-AS promotes tumor progression in gastric cancer by regulating miR-195/ HMGA1 axis. J Cell Biochem 2019;120:16921-33. [PMID: 31104318 DOI: 10.1002/jcb.28951] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
152 Park HS, Kim HS, Beom SH, Rha SY, Chung HC, Kim JH, Chun YJ, Lee SW, Choe EA, Heo SJ, Noh SH, Hyung WJ, Cheong JH, Kim HI, Son T, Lim JS, Baek SE, Jung M. Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial. Ann Surg Oncol 2018;25:3222-30. [PMID: 30051367 DOI: 10.1245/s10434-018-6624-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
153 Liu J, Yang C, Gu Y, Li C, Zhang H, Zhang W, Wang X, Wu N, Zheng C. Knockdown of the lncRNA SNHG8 inhibits cell growth in Epstein-Barr virus-associated gastric carcinoma. Cell Mol Biol Lett 2018;23:17. [PMID: 29736176 DOI: 10.1186/s11658-018-0070-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
154 Xiang H, Liu L, Gao Y, Ahene A, Macal M, Hsu AW, Dreiling L, Collins H. Population pharmacokinetic analysis of phase 1 bemarituzumab data to support phase 2 gastroesophageal adenocarcinoma FIGHT trial. Cancer Chemother Pharmacol 2020;86:595-606. [PMID: 32965540 DOI: 10.1007/s00280-020-04139-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Kozak J, Forma A, Czeczelewski M, Kozyra P, Sitarz E, Radzikowska-Büchner E, Sitarz M, Baj J. Inhibition or Reversal of the Epithelial-Mesenchymal Transition in Gastric Cancer: Pharmacological Approaches. Int J Mol Sci 2020;22:E277. [PMID: 33383973 DOI: 10.3390/ijms22010277] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
156 Kelly RJ, Lee J, Bang YJ, Almhanna K, Blum-Murphy M, Catenacci DVT, Chung HC, Wainberg ZA, Gibson MK, Lee KW, Bendell JC, Denlinger CS, Chee CE, Omori T, Leidner R, Lenz HJ, Chao Y, Rebelatto MC, Brohawn PZ, He P, McDevitt J, Sheth S, Englert JM, Ku GY. Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma. Clin Cancer Res. 2020;26:846-854. [PMID: 31676670 DOI: 10.1158/1078-0432.ccr-19-2443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
157 Qu X, Zhao L, Zhang R, Wei Q, Wang M. Differential microRNA expression profiles associated with microsatellite status reveal possible epigenetic regulation of microsatellite instability in gastric adenocarcinoma. Ann Transl Med 2020;8:484. [PMID: 32395528 DOI: 10.21037/atm.2020.03.54] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
158 Yang L, Wu Y, He H, Hu F, Li M, Mo L, Xiao Y, Wang X, Xie B. Delivery of BR2‐SOX17 fusion protein can inhibit cell survival, proliferation, and invasion in gastric cancer cells through regulating Klotho gene expression. Cell Biol Int 2020;44:2011-20. [DOI: 10.1002/cbin.11407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
159 Qi X, Liu Y, Wang W, Cai D, Li W, Hui J, Liu C, Zhao Y, Li G. Management of advanced gastric cancer: An overview of major findings from meta-analysis. Oncotarget. 2016;7:78180-78205. [PMID: 27655725 DOI: 10.18632/oncotarget.12102] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
160 Chun SH, Kim EY, Yoon JS, Won HS, Yim K, Hwang HW, Hong SA, Lee M, Lee SL, Kim SS, Sun S, Ko YH. Prognostic value of noggin protein expression in patients with resected gastric cancer. BMC Cancer 2021;21:558. [PMID: 34001012 DOI: 10.1186/s12885-021-08273-x] [Reference Citation Analysis]
161 Rao J, Fu J, Meng C, Huang J, Qin X, Zhuang S. LncRNA SNHG3 Promotes Gastric Cancer Cells Proliferation, Migration, and Invasion by Targeting miR-326. J Oncol 2021;2021:9935410. [PMID: 34257656 DOI: 10.1155/2021/9935410] [Reference Citation Analysis]
162 Song C, Duan C. Upregulation of FAM3B Promotes Cisplatin Resistance in Gastric Cancer by Inducing Epithelial-Mesenchymal Transition. Med Sci Monit 2020;26:e921002. [PMID: 32442162 DOI: 10.12659/MSM.921002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
163 Deng P, Li K, Gu F, Zhang T, Zhao W, Sun M, Hou B. LINC00242/miR-1-3p/G6PD axis regulates Warburg effect and affects gastric cancer proliferation and apoptosis. Mol Med 2021;27:9. [PMID: 33514309 DOI: 10.1186/s10020-020-00259-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]